Filed Pursuant to Rule 424(b)(5)
Registration No. 333-266623
PROSPECTUS SUPPLEMENT
(To Prospectus Dated August 8, 2022)
$850,000,000
![LOGO](https://capedge.com/proxy/424B5/0001193125-24-197099/g710667g51m40.jpg)
The Sherwin-Williams Company
$400,000,000 4.550% Senior Notes due 2028
$450,000,000 4.800% Senior Notes due 2031
We are offering $400,000,000 aggregate principal amount of 4.550% Senior Notes due 2028 (the “2028 notes”) and $450,000,000 aggregate principal amount of 4.800% Senior Notes due 2031 (the “2031 notes” and, together with the 2028 notes, the “notes”).
We will pay interest on the 2028 notes on March 1 and September 1 of each year, beginning on March 1, 2025. We will pay interest on the 2031 notes on March 1 and September 1 of each year, beginning on March 1, 2025. The 2028 notes will mature on March 1, 2028 and the 2031 notes will mature on September 1, 2031.
We may redeem some or all of the notes of each series at any time and from time to time prior to their maturity at the applicable redemption prices described under “Description of Notes—Optional Redemption.” If a Change of Control Triggering Event (as defined under “Description of Notes—Purchase of Notes upon a Change of Control Triggering Event”) occurs with respect to a series of notes, unless we have exercised our option to redeem the notes, we will be required to make an offer to each such holder to repurchase all or any part of that holder’s notes of such series in cash at a price equal to 101% of the principal amount of the notes of the applicable series repurchased, plus accrued and unpaid interest, if any, on the notes repurchased up to, but not including, the date of repurchase. See “Description of Notes—Purchase of Notes upon a Change of Control Triggering Event.”
The notes will be our general unsecured senior obligations and will rank equally in right of payment with all of our other unsecured senior indebtedness, whether currently existing or incurred in the future. The notes will be senior in right of payment to any subordinated indebtedness we may incur, and will be effectively junior in right of payment to our secured indebtedness to the extent of the value of the collateral securing that indebtedness. For a more detailed description of the notes, see “Description of Notes.”
Each series of notes is a new issue of securities with no established trading market. We do not intend to apply for the notes to be listed on any securities exchange or to arrange for the notes to be quoted on any quotation system.
Neither the Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of the notes or determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
| | | | | | | | | | | | | | | | |
| | Per 2028 Note | | | Total | | | Per 2031 Note | | | Total | |
Public offering price(1) | | | 99.997 | % | | $ | 399,988,000 | | | | 99.706 | % | | $ | 448,677,000 | |
Underwriting discount | | | 0.400 | % | | $ | 1,600,000 | | | | 0.625 | % | | $ | 2,812,500 | |
Proceeds (before expenses) to Sherwin-Williams | | | 99.597 | % | | $ | 398,388,000 | | | | 99.081 | % | | $ | 445,864,500 | |
(1) | Plus accrued interest, if any, from August 9, 2024, if settlement occurs after that date. |
See “Risk Factors” beginning on page S-9 of this prospectus supplement, “Risk Factors” on page 4 of the accompanying prospectus and similar headings in the other documents that are incorporated by reference into this prospectus supplement and the accompanying prospectus for a discussion of certain risks that you should consider in connection with an investment in the notes.
The underwriters expect to deliver the notes to purchasers through the book-entry delivery system of The Depository Trust Company (“DTC”) for the benefit of its participants, including Euroclear Bank SA/NV (“Euroclear”) and Clearstream Banking S.A. (“Clearstream”), on or about August 9, 2024, which is the second business day following the date of this prospectus supplement. Purchasers of the notes should note that trading of the notes may be affected by this settlement date. See “Underwriting (Conflicts of Interest).”
Joint Book-Running Managers
| | | | |
Citigroup | | US Bancorp | | Wells Fargo Securities |
| | | | | | |
BofA Securities | | J.P. Morgan |
Co-Managers
| | | | | | | | |
ING | | KeyBanc Capital Markets | | PNC Capital Markets LLC | | RBC Capital Markets | | Truist Securities |
| | | | | | | | |
| | | | |
Deutsche Bank Securities | | HSBC | | Goldman Sachs & Co. LLC | | | | ANZ Securities |
The date of this prospectus supplement is August 7, 2024.